19 July 2021
Clifford Chance advises Medlive Technology’s US$5.4 million Hong Kong IPO
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Christine Xu Lead | Clifford Chance | Partner | IPO | Not stated |
| Fang Liu Lead | Clifford Chance | Partner | IPO | Not stated |
| Gehuan Liu | Clifford Chance | Senior associate | IPO | Not stated |
| Queenie Tong | Clifford Chance | Senior associate | IPO | Not stated |
| Qingqing Bu | Clifford Chance | Senior associate | IPO | Not stated |
| Emma Bao | Clifford Chance | Senior associate | IPO | Not stated |
| Yumeng Fan | Clifford Chance | Trainee | IPO | Not stated |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 5.40m (US$5.4 million)
- What the figure measures
- Issue size
- Client
- Medlive TechnologyIssuer
- Counterparties
- Not stated